The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -- CLEAP 004 study.

Published in:

Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1310239

By:

• Chao-Xu Yang;
• Yang-Xun Pan;
• Feng Ye;
• Xiao-Dong Zhu;
• Jun Xue;
• Xi Li;
• Zhen-Gang Yuan;
• Lan Zhang;
• Li Xu;
• Yong-Jun Chen;
• Nan-Ya Wang;
• Hui-Chuan Sun;
• Xiu-Feng Liu

Publication type:

Article